tradingkey.logo
tradingkey.logo
Buscar

Hyperfine Inc

HYPR
Añadir a la lista de seguimiento
1.300USD
-0.040-2.99%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
91.43MCap. mercado
PérdidaP/E TTM

Más Datos de Hyperfine Inc Compañía

Hyperfine, Inc. is a health technology company. The Company is engaged in providing patient care globally through artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. Its Swoop Portable MR Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional magnetic resonance imaging (MRI) scanners. Its Swoop system is designed to transform brain MR for the patient, the clinician and the provider, enabling a highly differentiated experience for patients, timely imaging for clinicians, and favorable economics for hospital administrators. The Swoop system is a portable ULF MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. The Swoop system is FDA-cleared for brain imaging of patients of all ages. The Swoop system is commercially available in a select number of international markets.

Información de Hyperfine Inc

Símbolo de cotizaciónHYPR
Nombre de la empresaHyperfine Inc
Fecha de salida a bolsaJan 27, 2021
Director ejecutivoSainz (Maria Degois)
Número de empleados111
Tipo de seguridadOrdinary Share
Fin del año fiscalJan 27
Dirección351 New Whitfield Street
CiudadGUILFORD
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal06437
Teléfono18667966767
Sitio Webhttps://hyperfinemri.com/
Símbolo de cotizaciónHYPR
Fecha de salida a bolsaJan 27, 2021
Director ejecutivoSainz (Maria Degois)

Ejecutivos de Hyperfine Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Jonathan M. Rothberg, Ph.D.
Dr. Jonathan M. Rothberg, Ph.D.
Director
Director
981.21K
--
Mr. Thomas (Tom) Teisseyre, Ph.D.
Mr. Thomas (Tom) Teisseyre, Ph.D.
Chief Operating Officer
Chief Operating Officer
142.35K
-4.25%
Mr. Brett Hale
Mr. Brett Hale
Chief Financial Officer, Chief Administrative Officer, Chief Compliance Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Chief Administrative Officer, Chief Compliance Officer, Treasurer, Corporate Secretary
63.52K
-9.52%
Ms. Ruth A. Fattori
Ms. Ruth A. Fattori
Independent Director
Independent Director
20.48K
--
Mr. John Dahldorf
Mr. John Dahldorf
Independent Director
Independent Director
19.59K
--
Mr. Daniel J. Wolterman
Mr. Daniel J. Wolterman
Independent Chairman of the Board
Independent Chairman of the Board
19.59K
--
Ms. Maria Degois Sainz
Ms. Maria Degois Sainz
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Webb Campbell
Webb Campbell
Investor Relations
Investor Relations
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Jonathan M. Rothberg, Ph.D.
Dr. Jonathan M. Rothberg, Ph.D.
Director
Director
981.21K
--
Mr. Thomas (Tom) Teisseyre, Ph.D.
Mr. Thomas (Tom) Teisseyre, Ph.D.
Chief Operating Officer
Chief Operating Officer
142.35K
-4.25%
Mr. Brett Hale
Mr. Brett Hale
Chief Financial Officer, Chief Administrative Officer, Chief Compliance Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Chief Administrative Officer, Chief Compliance Officer, Treasurer, Corporate Secretary
63.52K
-9.52%
Ms. Ruth A. Fattori
Ms. Ruth A. Fattori
Independent Director
Independent Director
20.48K
--
Mr. John Dahldorf
Mr. John Dahldorf
Independent Director
Independent Director
19.59K
--
Mr. Daniel J. Wolterman
Mr. Daniel J. Wolterman
Independent Chairman of the Board
Independent Chairman of the Board
19.59K
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Hyperfine Inc?

Los cinco principales accionistas de Hyperfine Inc son: Dr. Jonathan M. Rothberg, Ph.D.

¿Cuántas instituciones poseen acciones de Hyperfine Inc (HYPR)?

A fecha de 2026Q1, 87 instituciones poseen acciones de Hyperfine Inc, con un valor de mercado combinado de aproximadamente 17.97M, lo que representa el 21.55% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 6988669.00.

¿Cuál es la mayor fuente de ganancias de Hyperfine Inc?

El 2026Q1, el segmento empresarial DEVICE generó la ganancia más alta para Hyperfine Inc, ascendiendo a 11.40M y representando el 84.04% de la ganancia total.